BusinessCrownBio’s Translatable FATZO Model Utilized in Eli Lilly’s Preclinical Type 2 Diabetes Research ProgramsBy Nasdaq OMXNov 21, 2017, 1:00 PM UTC
BusinessGallup and Sharecare Release New Research on the Cost of Diabetes to U.S. Communities and EmployersBy Nasdaq OMXNov 14, 2017, 1:01 PM UTC
BusinessPatient Entrepreneur Amin Zayani of Med Angel BV Selected as the Winner of the 2017 Lyfebulb-Novo Nordisk Innovation AwardBy Nasdaq OMXNov 8, 2017, 2:14 PM UTC
BusinessHelmsley Charitable Trust Awards $52 Million to Support the Global Platform for the Prevention of Autoimmune DiabetesBy Nasdaq OMXNov 6, 2017, 2:00 PM UTC
BusinessRise of Diabetes Epidemic Leads to Innovations in Diabetic Patient Care NationwideBy Nasdaq OMXNov 6, 2017, 1:30 PM UTC
BusinessSolera Health and the American Diabetes Association® Collaborate to Help Prevent and Delay Type 2 Diabetes for Millions of AmericansBy Nasdaq OMXOct 18, 2017, 2:00 PM UTC
BusinessBioForce Nanosciences Holdings, Inc. (BFNH) Moves Forward With Uplifting Requirements for OTCQB, Aggressively Pursues Take Over TargetsBy Nasdaq OMXOct 18, 2017, 1:15 PM UTC
BusinessCrownBio Enhances Its European Capabilities with New Generation of Innovative Translational Models for Obesity and DiabetesBy Nasdaq OMXOct 10, 2017, 1:32 PM UTC
